Picture of Blueprint Medicines logo

BPMC Blueprint Medicines Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Annual cashflow statement for Blueprint Medicines, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-348314-644-558-507
Depreciation
Non-Cash Items54.782.236397.399.6
Other Non-Cash Items
Changes in Working Capital9.72-15.6-23.7-53.8-41.1
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-278387-299-502-437
Capital Expenditures-14-3.16-3.09-8.92-16.1
Purchase of Fixed Assets
Other Investing Cash Flow Items-2.45-431-223-141290
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-16.5-434-226-150274
Financing Cash Flow Items-0.400416-0.044
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities34161850.7562119
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash46.2570-475-90.2-43.4